Director/PDMR Shareholding

RNS Number : 3181Z

GlaxoSmithKline PLC

05 March 2013

 



Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of a Director and Persons Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value price of £14.55 per Ordinary Share on 1 March 2013 to meet tax liabilities following the vesting of awards granted under the GlaxoSmithKline 2009 Performance Share Plan (PSP).

	Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award
Sir Andrew Witty*	63,152
Mr S Bicknell	6,973
Mr M Dunoyer	3,501
Mr A Hussain	2,789
Mr D Redfern	7,908
Ms C Thomas	12,139

* Denotes an Executive Director

The table below sets out changes in the interests of a Director and PDMRs in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADS at a fair market value price of $44.03 per ADS on 1 March 2013 to meet tax liabilities following the vesting of awards granted under the PSP.

	Number of ADS withheld to meet tax liabilities following the vesting of a PSP award
Dr M Slaoui*	17,232
Ms D Connelly	5,439
Mr W Louv	3,470
Mr D Troy	6,360

* Denotes an Executive Director

The Company, Directors and PDMRs were advised of these transactions on 4 March 2013.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

5 March 2013

 

END

 

 

RDSDELFBXXFXBBK